Jul 02, 2020 · The Chiasma Inc. (CHMA) shares are trading at lower $4.65 and the avg recommendation for the stock is Moderate Buy. To add more color to this target, the company’s high over the last year is $9.25 and the low is $2.88. Over the last 52 weeks, CHMA is down -49.73% while the S&P 500 is up 0.70%.
On Wednesday morning, Chiasma, Inc. (NASDAQ: CHMA) announced the pricing of a public offering of common stock and pre-funded warrants. Jul 17, 2020 · Are Options Traders Betting on a Big Move in Chiasma (CHMA) Stock? Investors need to pay close attention to Chiasma (CHMA) stock based on the movements in the options market lately. Jun. 29, 2020 Jul 20, 2020 · Real-time trade and investing ideas on Chiasma CHMA from the largest community of traders and investors. Chiasma's stock was trading at $3.92 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CHMA shares have increased by 24.4% and is now trading at $4.8750. View which stocks have been most impacted by Coronavirus. Learn about CHMA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CHMA. Real time Chiasma (CHMA) stock price quote, stock graph, news & analysis. Chiasma, Inc. Common Stock (CHMA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Jul 20, 2020 · Chiasma Inc. company facts, information and stock details by MarketWatch. View chma business summary and other industry information.
You can buy and sell Chiasma (CHMA) stock and options and many more commission-free on Robinhood with real-time quotes, market data, and relevant news. 1,387 people own Chiasma on Robinhood on July 24, 2020. CHMA Stock Analysis Overview . What this means: InvestorsObserver gives Chiasma Inc (CHMA) an overall rank of 44, which is below average. Chiasma Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.
Check out our CHMA stock analysis, current CHMA quote, charts, and historical prices for Chiasma Inc stock
Chiasma (CHMA) Stock Plummets on Disappointing FDA Letter. By Rachel Graf. Apr 18, 2016 1:12 PM EDT. INVESTING. Chiasma plunges after FDA rejects application for growth disorder drug. Jul 20, 2020 · Chiasma, Inc. (CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its proprietary Transient Permeability Enhancer delivery platform technology to reduce the burden of chronic injections for people with rare diseases, today announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock As CHMA breaks its upward wedge pattern, a short position is entered with a tight stop. Factors leading to the decision: Huge rejection at the ATH, creating a new major down-trend Lower trendline of an upward wedge has been broken Heavier bearish volume showed up at prior dip, getting the attention of short sellers Price came back up and re-tested the CHMA Stock Price Chart Technical Analysis Charts. CHMA Price/Volume Stats. Current price $4.67 : 52-week high $9.25 : Prev. close $4.65 : 52-week low $2.88 : Day low CHMA, Chiasma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Chiasma Inc. (NASDAQ: CHMA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. CHMA stock quote, chart and news. Get Chiasma, Inc.'s stock price today.